Despite clearly established guidelines, recent audits have found the conduct and reporting
of systematic reviews and meta-analyses (SRMAs) within neurosurgery to be relatively …

Introduction Meningiomas are associated with several gonadal steroid hormone-related risk
factors and demonstrate a predominance in females. These associations led to …

Purpose To report the results of systematic meningioma screening program implemented by
French authorities in patients exposed to progestin therapies (cyproterone (CPA) …

Objective Transgender women take gender-affirming hormone therapy (GAHT) to affirm their
gender identity and improve quality of life and well-being. Usually, GAHT in transgender …

Context Transgender people with sex recorded male at birth desiring feminization commonly
use cyproterone acetate or spironolactone as antiandrogens with estradiol, but the optimal …

Introduction Hirsutism is the presence of excessive body hair in a male pattern distribution in
a woman, and can affect up to 20% of women. It can be associated with high levels of …

Transgender individuals that undergo gender-affirming hormone therapy may experience
discrimination in the health care setting with a lack of access to medical personnel …

The most common type of alopecia in women is female androgenetic alopecia (FAGA),
characterized by progressive hair loss in a patterned distribution. Many oral therapies …

Background The number of individuals who sexually offended, and who are continued to be
treated with pharmacological agents to reduce sex drive after their release from prison or …

Angus et al, in their article titled “Effect of Spironolactone and Cyproterone Acetate on Breast
Growth in Transgender People: A Randomized Clinical Trial,” found no statistically …